HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.

AbstractPURPOSE:
The EphA2 receptor tyrosine kinase is believed to play a role in tumor growth and metastasis. The clinical significance of the expression of EphA2 was observed in breast, prostate, colon, skin, cervical, ovarian, and lung cancers. The purpose of this work was to determine the expression of EphA2 and its ligand, Ephrin A-1, and E-cadherin in carcinoma of the urinary bladder, and determine EphA2 as a new target for therapy in bladder cancer.
EXPERIMENTAL DESIGN:
EphA2 mRNA and protein expression was investigated by reverse transcription-PCR and Western blot, respectively, in bladder cancer cell lines. In addition, the expression of EphA2, Ephrin A-1, and E-cadherin in tissues from patients with different stages of urinary bladder cancer was determined by immunohistochemistry. Furthermore, the ability of Ephrin A-1 to inhibit growth of bladder cancer cells was also investigated using an adenoviral delivery system.
RESULTS:
Western blot analysis showed high EphA2 expression in TCCSUP, T24, and UMUC-3 cell lines. In tissues, the staining intensity of EphA2 was less in normal urothelium but increased greatly in advancing stages of urothelial carcinoma (P < 0.05). Similarly, the staining intensity of Ephrin A-1 was low in normal tissues and high in cancerous tissues, but it was similar across the various stages of urothelial carcinoma (T(a)-T(4)). E-cadherin immunoreactivity decreased in urothelial cancer. Association of EphA2 and Ephrin A-1 expression was found to be significant between T(a) stage and T(1)-T(2) (P < 0.04) and T(a) and T(3)-T(4) stages (P < 0.0001). Adenovirus delivery of Ephrin A-1 inhibited proliferation of TCCSUP cells.
CONCLUSION:
EphA2 may serve as a novel target for bladder cancer therapy.
AuthorsShaji Abraham, Deborah W Knapp, Liang Cheng, Paul W Snyder, Suresh K Mittal, Dinesh S Bangari, Michael Kinch, Lan Wu, Jay Dhariwal, Sulma I Mohammed
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 12 Issue 2 Pg. 353-60 (Jan 15 2006) ISSN: 1078-0432 [Print] United States
PMID16428472 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cadherins
  • Ephrin-A1
  • RNA, Messenger
  • Receptor, EphA2
Topics
  • Adenoviridae (genetics)
  • Blotting, Western
  • Cadherins (genetics, metabolism)
  • Cell Proliferation
  • Ephrin-A1 (metabolism)
  • Humans
  • Immunoenzyme Techniques
  • Lymphatic Metastasis (pathology)
  • Neoplasm Staging
  • RNA, Messenger (metabolism)
  • Receptor, EphA2 (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms (genetics, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: